Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to characterize and evaluate risk factors of polyomavirus
nephropathy (PVN) including the impact of three immunosuppressive regimens.
Phase:
Phase 4
Details
Lead Sponsor:
University of Giessen
Collaborators:
Astellas Pharma Inc Heidelberg University Hoffmann-La Roche Novartis